BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9443983)

  • 1. Increased sensitivity and reproducibility of TRAP assay by avoiding direct primers interaction.
    Falchetti ML; Levi A; Molinari P; Verna R; D'Ambrosio E
    Nucleic Acids Res; 1998 Feb; 26(3):862-3. PubMed ID: 9443983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of telomerase activity in high concentration of cell lysates using primer-modified gold nanoparticles.
    Xiao Y; Dane KY; Uzawa T; Csordas A; Qian J; Soh HT; Daugherty PS; Lagally ET; Heeger AJ; Plaxco KW
    J Am Chem Soc; 2010 Nov; 132(43):15299-307. PubMed ID: 20932008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity.
    Wege H; Chui MS; Le HT; Tran JM; Zern MA
    Nucleic Acids Res; 2003 Jan; 31(2):E3-3. PubMed ID: 12527792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity.
    Wright WE; Shay JW; Piatyszek MA
    Nucleic Acids Res; 1995 Sep; 23(18):3794-5. PubMed ID: 7479015
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP).
    Kim NW; Wu F
    Nucleic Acids Res; 1997 Jul; 25(13):2595-7. PubMed ID: 9185569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomeric repeat amplification, without shortening or lengthening of the telomerase products: a method to analyze the processivity of telomerase enzyme.
    Szatmari I; Aradi J
    Nucleic Acids Res; 2001 Jan; 29(2):E3. PubMed ID: 11139633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment and quantification of telomerase enzyme activity.
    Maritz MF; Richards LA; Mackenzie KL
    Methods Mol Biol; 2013; 965():215-31. PubMed ID: 23296661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity.
    Hou M; Xu D; Björkholm M; Gruber A
    Clin Chem; 2001 Mar; 47(3):519-24. PubMed ID: 11238306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid biosensor chip assay for measuring of telomerase activity using surface plasmon resonance.
    Maesawa C; Inaba T; Sato H; Iijima S; Ishida K; Terashima M; Sato R; Suzuki M; Yashima A; Ogasawara S; Oikawa H; Sato N; Saito K; Masuda T
    Nucleic Acids Res; 2003 Jan; 31(2):E4-4. PubMed ID: 12527793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of telomerase activity utilizing energy transfer primers: comparison with gel- and ELISA-based detection.
    Uehara H; Nardone G; Nazarenko I; Hohman RJ
    Biotechniques; 1999 Mar; 26(3):552-8. PubMed ID: 10090999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time telomeric repeat amplification protocol using the duplex scorpion and two reverse primers system: the high sensitive and accurate method for quantification of telomerase activity.
    Huang YP; Liu ZS; Tang H; Liu M; Li X
    Clin Chim Acta; 2006 Oct; 372(1-2):112-9. PubMed ID: 16714009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative method to measure telomerase activity by bioluminescence connected with telomeric repeat amplification protocol.
    Xu S; He M; Yu H; Cai X; Tan X; Lu B; Shu B
    Anal Biochem; 2001 Dec; 299(2):188-93. PubMed ID: 11730342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fluorescent method for detection of telomerase activity.
    Aldous WK; Grabill NR
    Diagn Mol Pathol; 1997 Apr; 6(2):102-10. PubMed ID: 9098649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplified method for the telomeric repeat amplification protocol (TRAP).
    Sellner LN; Lock PM; Turbett GR
    Biotechniques; 1998 May; 24(5):726-8. PubMed ID: 9591115
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonradioisotopic telomeric repeat amplification protocol (TRAP) using digoxigenin labeled probe.
    Wada Y; Yagihashi A; Kameshima H; Matsuura A; Sato N; Kikuchi K; Yajima T; Sasaki K; Uehara N; Watanabe N; Hirata K
    Immunopharmacol Immunotoxicol; 1997 Nov; 19(4):451-7. PubMed ID: 9436045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay.
    Gomez D; Mergny JL; Riou JF
    Cancer Res; 2002 Jun; 62(12):3365-8. PubMed ID: 12067975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of artifacts in the detection of telomerase activity and a modified primer for a more robust 'TRAP' assay.
    Krupp G; Kühne K; Tamm S; Klapper W; Heidorn K; Rott A; Parwaresch R
    Nucleic Acids Res; 1997 Feb; 25(4):919-21. PubMed ID: 9016650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase activity in human chorionic villi and placenta determined by TRAP and in situ TRAP assay.
    Izutsu T; Kudo T; Sato T; Nishiya I; Ohyashiki K; Mori M; Nakagawara K
    Placenta; 1998 Nov; 19(8):613-8. PubMed ID: 9859865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
    Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New method to measure telomerase activity by transcription-mediated amplification and hybridization protection assay.
    Hirose M; Abe-Hashimoto J; Tahara H; Ide T; Yoshimura T
    Clin Chem; 1998 Dec; 44(12):2446-52. PubMed ID: 9836711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.